Search

8649 results for: ‘global learning outcomes’

  • Practice Education 2

    Module code: PH2007 This module continues the practice education placement experience you started during PH2006 Practice Education 1.

  • Practice Education 5

    Module code: PH3006 During this module, you will continue the placement started in your Practice Education modules, completing the 1,000 hours of clinical practice required to qualify as an HCPC and CSP accredited physiotherapist.

  • Practice Education 3

    Module code: PH3004 During this module, you will continue to attain the 1,000 hours of clinical practice required to qualify as an HCPC and CSP accredited physiotherapist.

  • Approaching Ancient Evidence (Greek)

    Module Code: AH1008 This module is the essential first step in your training as a Greek historian. Through a combination of lectures and small-group seminars, you will be taught the key skills for dealing with ancient evidence.

  • Criminological Research Methods

    Module code: CR7146 (double module) This module will provide a comprehensive grounding in the research methodologies employed in criminological research.

  • Students

    Get more information on how your data is handled as an applicant or student of the University of Leicester.

  • Standing Together

    The narrative thus far has been about standing together against unacceptable behaviours. The ultimate aim has to be moving towards standing together for something more positive.

  • Ascen Pagan

    The academic profile of Dr Ascen Pagan, Lecturer at University of Leicester

  • CITE Mission and Vision Statements

    Our Mission Provide excellent teaching and support to the diverse range of groups and individuals that we engage with.   Our Vision To be the leading centre of its kind in the UK and internationally recognised for its excellence.

  • New hope for patients with aggressive asbestos-linked cancer as trial shows a targeted cancer treatment can improve survival

    Leicester researchers have shown for the first time that a drug that prevents cancer cells from repairing can control the growth of mesothelioma, a rare and aggressive form of cancer caused by asbestos

Back to top
MENU